Cargando…

Clinical nomogram for lymph node metastasis in pathological T1 esophageal squamous cell carcinoma: a multicenter retrospective study

BACKGROUND: Endoscopic resection is increasingly used to treat pathological T1 (pT1) esophageal cancer (EC) patients. However, the procedures are limited by lymph node metastasis (LNM) and remain controversial. We aimed to construct a nomogram to predict the risk of LNM in patients with pT1 esophage...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Dong, Jiang, Kai-Yuan, Huang, Heng, Jian, Shun-Hai, Zheng, Yin-Bin, Guo, Xiao-Guang, Li, Hong-Yun, Zhang, Jing-Qiu, Guo, Ke-Xuan, Wen, Hong-Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186726/
https://www.ncbi.nlm.nih.gov/pubmed/32355736
http://dx.doi.org/10.21037/atm.2020.02.185
_version_ 1783527015022854144
author Tian, Dong
Jiang, Kai-Yuan
Huang, Heng
Jian, Shun-Hai
Zheng, Yin-Bin
Guo, Xiao-Guang
Li, Hong-Yun
Zhang, Jing-Qiu
Guo, Ke-Xuan
Wen, Hong-Ying
author_facet Tian, Dong
Jiang, Kai-Yuan
Huang, Heng
Jian, Shun-Hai
Zheng, Yin-Bin
Guo, Xiao-Guang
Li, Hong-Yun
Zhang, Jing-Qiu
Guo, Ke-Xuan
Wen, Hong-Ying
author_sort Tian, Dong
collection PubMed
description BACKGROUND: Endoscopic resection is increasingly used to treat pathological T1 (pT1) esophageal cancer (EC) patients. However, the procedures are limited by lymph node metastasis (LNM) and remain controversial. We aimed to construct a nomogram to predict the risk of LNM in patients with pT1 esophageal squamous cell carcinoma (ESCC). METHODS: A total of 243 patients with pT1 ESCC who underwent esophagectomy and lymph node dissection at two different institutes between February 2013 and June 2019 were analyzed retrospectively. Patients were categorized into the negative group and the positive group according to whether there was LNM. Risk factors for LNM were evaluated by univariate and multivariate analyses. The nomogram was used to estimate the individual risk of LNM. RESULTS: Forty-six (18.9%) of the 243 patients with pT1 ESCC exhibited LNM. The LNM rate in patients with stage T1a disease was 5.7% (5/88), and the rate in patients with stage T1b disease was 26.5% (41/155). Multivariable logistic regression analysis showed that tumor differentiation [odds ratio (OR) =1.942, 95% confidence interval (CI): 1.067–3.536, P=0.030], the T1 sub-stage (OR =4.750, 95% CI: 1.658–13.611, P=0.004), the preoperative alanine aminotransferase/aspartate aminotransferase ratio (LSR) (OR =5.371, 95% CI: 1.676–17.210, P=0.005), and the high-density lipoprotein cholesterol (HDL-C) level (OR =5.894, 95% CI: 1.917–18.124, P=0.002) were independent risk factors for LNM. The nomogram had relatively high accuracy, with an area under the receiver operating characteristic curve (AUC) of 0.803 (95% CI: 0.732–0.873). The calibration curve showed that the predicted probability of LNM was in good agreement with the actual probability. CONCLUSIONS: Clinicopathological and hematological parameters of tumor differentiation, the T1 sub-stage, the preoperative LSR, and the HDL-C level may predict the risk of LNM in T1 ESCC. The risk of LNM can be predicted by the nomogram.
format Online
Article
Text
id pubmed-7186726
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-71867262020-04-30 Clinical nomogram for lymph node metastasis in pathological T1 esophageal squamous cell carcinoma: a multicenter retrospective study Tian, Dong Jiang, Kai-Yuan Huang, Heng Jian, Shun-Hai Zheng, Yin-Bin Guo, Xiao-Guang Li, Hong-Yun Zhang, Jing-Qiu Guo, Ke-Xuan Wen, Hong-Ying Ann Transl Med Original Article BACKGROUND: Endoscopic resection is increasingly used to treat pathological T1 (pT1) esophageal cancer (EC) patients. However, the procedures are limited by lymph node metastasis (LNM) and remain controversial. We aimed to construct a nomogram to predict the risk of LNM in patients with pT1 esophageal squamous cell carcinoma (ESCC). METHODS: A total of 243 patients with pT1 ESCC who underwent esophagectomy and lymph node dissection at two different institutes between February 2013 and June 2019 were analyzed retrospectively. Patients were categorized into the negative group and the positive group according to whether there was LNM. Risk factors for LNM were evaluated by univariate and multivariate analyses. The nomogram was used to estimate the individual risk of LNM. RESULTS: Forty-six (18.9%) of the 243 patients with pT1 ESCC exhibited LNM. The LNM rate in patients with stage T1a disease was 5.7% (5/88), and the rate in patients with stage T1b disease was 26.5% (41/155). Multivariable logistic regression analysis showed that tumor differentiation [odds ratio (OR) =1.942, 95% confidence interval (CI): 1.067–3.536, P=0.030], the T1 sub-stage (OR =4.750, 95% CI: 1.658–13.611, P=0.004), the preoperative alanine aminotransferase/aspartate aminotransferase ratio (LSR) (OR =5.371, 95% CI: 1.676–17.210, P=0.005), and the high-density lipoprotein cholesterol (HDL-C) level (OR =5.894, 95% CI: 1.917–18.124, P=0.002) were independent risk factors for LNM. The nomogram had relatively high accuracy, with an area under the receiver operating characteristic curve (AUC) of 0.803 (95% CI: 0.732–0.873). The calibration curve showed that the predicted probability of LNM was in good agreement with the actual probability. CONCLUSIONS: Clinicopathological and hematological parameters of tumor differentiation, the T1 sub-stage, the preoperative LSR, and the HDL-C level may predict the risk of LNM in T1 ESCC. The risk of LNM can be predicted by the nomogram. AME Publishing Company 2020-03 /pmc/articles/PMC7186726/ /pubmed/32355736 http://dx.doi.org/10.21037/atm.2020.02.185 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Tian, Dong
Jiang, Kai-Yuan
Huang, Heng
Jian, Shun-Hai
Zheng, Yin-Bin
Guo, Xiao-Guang
Li, Hong-Yun
Zhang, Jing-Qiu
Guo, Ke-Xuan
Wen, Hong-Ying
Clinical nomogram for lymph node metastasis in pathological T1 esophageal squamous cell carcinoma: a multicenter retrospective study
title Clinical nomogram for lymph node metastasis in pathological T1 esophageal squamous cell carcinoma: a multicenter retrospective study
title_full Clinical nomogram for lymph node metastasis in pathological T1 esophageal squamous cell carcinoma: a multicenter retrospective study
title_fullStr Clinical nomogram for lymph node metastasis in pathological T1 esophageal squamous cell carcinoma: a multicenter retrospective study
title_full_unstemmed Clinical nomogram for lymph node metastasis in pathological T1 esophageal squamous cell carcinoma: a multicenter retrospective study
title_short Clinical nomogram for lymph node metastasis in pathological T1 esophageal squamous cell carcinoma: a multicenter retrospective study
title_sort clinical nomogram for lymph node metastasis in pathological t1 esophageal squamous cell carcinoma: a multicenter retrospective study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186726/
https://www.ncbi.nlm.nih.gov/pubmed/32355736
http://dx.doi.org/10.21037/atm.2020.02.185
work_keys_str_mv AT tiandong clinicalnomogramforlymphnodemetastasisinpathologicalt1esophagealsquamouscellcarcinomaamulticenterretrospectivestudy
AT jiangkaiyuan clinicalnomogramforlymphnodemetastasisinpathologicalt1esophagealsquamouscellcarcinomaamulticenterretrospectivestudy
AT huangheng clinicalnomogramforlymphnodemetastasisinpathologicalt1esophagealsquamouscellcarcinomaamulticenterretrospectivestudy
AT jianshunhai clinicalnomogramforlymphnodemetastasisinpathologicalt1esophagealsquamouscellcarcinomaamulticenterretrospectivestudy
AT zhengyinbin clinicalnomogramforlymphnodemetastasisinpathologicalt1esophagealsquamouscellcarcinomaamulticenterretrospectivestudy
AT guoxiaoguang clinicalnomogramforlymphnodemetastasisinpathologicalt1esophagealsquamouscellcarcinomaamulticenterretrospectivestudy
AT lihongyun clinicalnomogramforlymphnodemetastasisinpathologicalt1esophagealsquamouscellcarcinomaamulticenterretrospectivestudy
AT zhangjingqiu clinicalnomogramforlymphnodemetastasisinpathologicalt1esophagealsquamouscellcarcinomaamulticenterretrospectivestudy
AT guokexuan clinicalnomogramforlymphnodemetastasisinpathologicalt1esophagealsquamouscellcarcinomaamulticenterretrospectivestudy
AT wenhongying clinicalnomogramforlymphnodemetastasisinpathologicalt1esophagealsquamouscellcarcinomaamulticenterretrospectivestudy